Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 4/1999

01-10-1999 | Review Article

Selectivity of Cholinesterase Inhibition

Clinical Implications for the Treatment of Alzheimer’s Disease

Author: Prof. Marta Weinstock

Published in: CNS Drugs | Issue 4/1999

Login to get access
Metadata
Title
Selectivity of Cholinesterase Inhibition
Clinical Implications for the Treatment of Alzheimer’s Disease
Author
Prof. Marta Weinstock
Publication date
01-10-1999
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 4/1999
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-199912040-00005

Other articles of this Issue 4/1999

CNS Drugs 4/1999 Go to the issue

Current Opinion

Potential Sensitising Effects of Antidepressant Drugs on Depression

Disease Management

Obsessive-Compulsive Disorder in Children and Adolescents

Adis New Drug Profile

Eletriptan

Adis New Drug Profile

Eletriptan

Adis New Drug Profile

Eletriptan

Review Article

Noradrenaline (Norepinephrine) and Depression